RSV Vaccine for Adults: Studies, Uses, and Patient Conversations - Frankly Speaking Ep 346

episode

Frankly Speaking About Family Medicine not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Frankly Speaking About Family Medicine

2026 ACC/AHA Dyslipidemia Guideline Review: Getting to the Heart of the Evidence - Frankly Speaking Ep 497 16 min · 10 Aug 2026

The Cannabis Conversation: Discussing the Risks with Adolescent Patients - Frankly Speaking Ep 496 13 min · 03 Aug 2026

Statins—Time to Stop the Worry! - Frankly Speaking Ep 495 11 min · 27 Jul 2026

Digital Dependence: Screening Adults for Screen Time - Frankly Speaking Ep 494 11 min · 20 Jul 2026

From Guidelines to Practice: Managing CKD in Primary Care - Frankly Speaking Ep 493 13 min · 13 Jul 2026

SPAN Small Changes to a Longer, Healthier Life - Frankly Speaking Ep 492 13 min · 06 Jul 2026

All episodes from Frankly Speaking About Family Medicine →

Report any issue

Source

Recorded18 Sep 2023

Publisherfeed.podbean.com ↗

Handlerec:9022565

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346 Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. Episode resource links: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in